Eun Ju Sohn

Title: Eun Ju Sohn: Innovator in Protein Isolation and Vaccine Development

Introduction

Eun Ju Sohn is a prominent inventor based in Pohang-si, South Korea. She has made significant contributions to the fields of biotechnology and protein engineering, holding a total of four patents. Her work focuses on innovative methods for isolating proteins and developing vaccine compositions.

Latest Patents

One of her latest patents is a recombinant vector carrying a cellulose-binding domain and a method for isolating and purifying proteins using the same vector. This invention relates to a recombinant vector that facilitates the separation of target proteins by binding transformed plant bodies to cellulose. The method allows for the effective isolation of fusion proteins, which can be treated with enterokinase to separate the target protein. This technology is expected to have industrial applications across various fields.

Another notable patent is a vaccine composition for classical swine fever derived from plants, along with its manufacturing method. This invention includes a recombinant vector for transforming plants, a plant transformed with the vector, and a plant-made classical swine fever virus antigen pmE2 protein. The recombinant vector encodes a GP55 protein of the classical swine fever virus and a cellulose-binding domain protein. The resulting plant-derived antigen is produced with high efficiency and offers enhanced safety and stability compared to traditional production methods.

Career Highlights

Eun Ju Sohn has worked with several organizations, including Bioapplications Inc. and the Republic of Korea's Animal and Plant Quarantine Agency. Her experience in these institutions has contributed to her expertise in biotechnology and protein research.

Collaborations

Throughout her career, Eun Ju has collaborated with notable colleagues, including Yong Jik Lee and Inhwan Hwang. These partnerships have furthered her research and development efforts in the field.

Conclusion

Eun Ju Sohn is a trailblazer in the realm of protein isolation and vaccine development, with her innovative patents paving the way for advancements in biotechnology. Her contributions are expected to have a lasting impact on various industries.